4551.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 08:15):

Stats
Dagens volum	48 200.00
Gjennomsnittsvolum	31 521.00
Markedsverdi	108.35B
EPS	¥0 ( 2024-04-25 )
Last Dividend	¥50.00 ( 2023-06-29 )
Next Dividend	¥0 ( N/A )
P/E	26.32
ATR14	¥5.18 (0.13%)

Volum Korrelasjon

Lang: 0.15 (neutral)

Kort: 0.40 (neutral)

Signal:(54.642) Neutral

Torii Pharmaceutical Co., Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Torii Pharmaceutical Co., Korrelasjon - Valuta/Råvare

0.94
( very strong )

0.65
( weak )

0.86
( strong )

-0.77
( moderate negative )

-0.87
( strong negative )

Torii Pharmaceutical Co., Økonomi

Annual	2023
Omsetning:	¥54.64B
Bruttogevinst:	¥24.57B (44.97 %)
EPS:	¥146.57

FY	2023
Omsetning:	¥54.64B
Bruttogevinst:	¥24.57B (44.97 %)
EPS:	¥146.57

FY	2022
Omsetning:	¥48.89B
Bruttogevinst:	¥23.38B (47.81 %)
EPS:	¥140.38

FY	2021
Omsetning:	¥46.99B
Bruttogevinst:	¥24.34B (51.80 %)
EPS:	¥32.16

Financial Reports:

No articles found.

Torii Pharmaceutical Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥76.00 (N/A)	¥0 (N/A)	¥50.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Torii Pharmaceutical Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 7.39 - good (73.87%) | Divividend Growth Potential Score: 3.44 - Decrease likely (31.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.00	2001-03-27
Last Dividend	¥50.00	2023-06-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	47	--
Total Paid Out	¥907.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.09	--
Div. Sustainability Score	7.39
Div.Growth Potential Score	3.44
Div. Directional Score	5.41	--

Next Divdend (Est)
(2024-09-25)

¥0 Estimate 3.76 %

Dividend Stability

0.30 Poor

Dividend Score

3.09

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8424.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7826.T	Ex Dividend Junior	2024-06-27	Annually	0.00%
6981.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6331.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
5187.T	Ex Dividend Knight	2023-06-29	Semi-Annually	0.00%
4290.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3468.T	Ex Dividend Junior	2023-07-28	Semi-Annually	0.00%
2674.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
9533.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8133.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0939	1.500	8.12	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0398	1.200	8.67	10.00	[0 - 0.3]
returnOnEquityTTM	0.0444	1.500	-0.618	-0.927	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	6.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.20	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.280	1.500	9.56	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.448	1.000	5.86	5.86	[0.2 - 0.8]
operatingProfitMarginTTM	0.122	1.000	9.56	9.56	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.423	0.800	-0.511	-0.409	[0.5 - 2]
Total Score				7.39

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.50	1.000	8.03	0	[1 - 100]
returnOnEquityTTM	0.0444	2.50	-0.397	-0.927	[0.1 - 1.5]
freeCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	3.11	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.448	1.500	-0.349	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0163	1.000	-2.09	0	[0.1 - 0.5]
Total Score				3.44

Torii Pharmaceutical Co.,

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.